NAVIDEA BIOPHARMACEUTICALS, INC. of DUBLIN, OH filed a DEF 14A with the SEC on 2004-06-16. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | NEOPROBE CORPORATION DEFINITIVE PROXY |
Showing 12 of 57 filings.
| Filed | Form |
|---|---|
| 2023-11-13 | DEFA14A |
| 2023-10-05 | DEF 14A |
| 2023-09-15 | PRE 14A |
| 2023-07-03 | DEF 14A |
| 2023-06-16 | PRE 14A |
| 2022-10-24 | DEF 14A |
| 2022-10-13 | PRE 14A |
| 2021-08-02 | DEF 14A |
| 2020-07-31 | DEF 14A |
| 2019-06-28 | DEFA14A |
| 2019-06-28 | DEF 14A |
| 2018-08-16 | DEFA14A |